R&D

Clinical Development Services Agency (CDSA) is an extramural unit of THSTI and has been established as a not-for-profit society to provide cost effective, high quality preclinical and clinical product development support services to meet the country's growing healthcare needs. It will tend enterprises - particularly SMEs involved in new technology innovation and facilitate translation of scientific know-how into viable products.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Eisai Co., Ltd. based in Tokyo, Japan is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline.

Birla Institute of Technology (Deemed University u/s 3 of UGC Act 1956) is one of the premier institutes imparting education and conducting research in the fields of Engineering, Management, Architecture and Pharmaceutical Sciences.